In fact, several studies demonstrated Eomes and T-bet co-expression in tumor-reactive CD4+ CTL, thereby emphasizing the link between cytotoxic and Th1 differentiation programs (7, 8, 12). The gene discussed is CD4; the disease is neoplasm.